Status:
COMPLETED
Ketamine for Acute Pain Management After Trauma
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Trauma Injury
Pain
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effectiveness of Ketamine drip along with usual care and usual care alone on trauma patients and to longitudinally quantify the pain experience of patients ...
Eligibility Criteria
Inclusion
- Adult trauma patients
- Admission to Shock Trauma ICU (STICU) or Surgical Intermediate Unit (SIMU)
- Randomization within 6 hours of arrival
Exclusion
- Patient not expected to survive
- Contraindications to ketamine Allergy, Poorly controlled hypertension, Cardiac arrhythmia disorders (including atrial fibrillation), congestive heart failure, unstable coronary artery disease or recent myocardial infarction( MI)(within 6 months), cirrhosis, seizure disorder, and for those patients with unknown medical history - median sternotomy scar, mechanism of injury is fall from standing, 65 years of age or older, any arrhythmia on EKD)
- pregnancy
- in police custody
- history of dementia or movement disorder (i.e. Parkinson's)
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT04129086
Start Date
July 1 2020
End Date
September 30 2022
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030